Capula Management LTD Ptc Therapeutics, Inc. Transaction History
Capula Management LTD
- $9.84 Billion
- Q2 2025
A detailed history of Capula Management LTD transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Capula Management LTD holds 7,126 shares of PTCT stock, worth $449,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,126
Previous 5,882
21.15%
Holding current value
$449,080
Previous $299,000
16.39%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
308Shares Held
80.1MCall Options Held
255KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA8.85MShares$558 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$490 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$488 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$298 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$296 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.51B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...